Peer-influenced content. Sources you trust. No registration required. This is HCN.
DocWire News
The targeted chemotherapy pill AOH1996, developed by the City of Hope, has shown promising results in preclinical research by targeting PCNA, a protein once thought to be too challenging for targeted therapy. Explore the potential of this novel approach as it advances to phase 1 clinical trials.
Oncology, Medical August 14th 2023
Cancer Care Business Exchange (CBEx)
The chemotherapy shortage in the US is a pressing issue that demands a reevaluation of health policies. Dive deeper into the potential strategies for mitigating its impact, from creating a market for high-quality generics to convening a multi-stakeholder task force.
Oncology, Medical August 7th 2023
Cancer Therapy Advisor
Malnutrition is a pressing issue in cancer care, with studies highlighting its significant influence on treatment outcomes and mortality rates. Exploring strategies for prevention, treatment, and ongoing support is vital to improve patient quality of life and success in cancer treatment.
Nursing August 1st 2023
Journal of Clinical Pathways
This comprehensive research highlights favorable outcomes with Cigna’s home-redirection program for pegfilgrastim administration in CIN prophylaxis, including a 32% reduction in specific complications. Explore how this study may influence future healthcare delivery models, enhancing both clinical efficacy and affordability.
Hematology/Oncology August 1st 2023
Pharmacy Practice News
The application of NIOSH Hazardous Drug Assessment principles to home healthcare is a critical development in ensuring safety. As home delivery of treatments like chemotherapy grows, understanding and implementing these principles become vital for healthcare professionals, patients, and their families. Explore how these principles are being adapted to protect all involved in this complex process.
Clinical Pharmacology July 31st 2023
Dr. Janet L. Espirito’s groundbreaking research demonstrates how real-world data can effectively be used to evaluate therapeutic responses in patients with mNSCLC. Discover how this innovative approach could shape the future of oncology treatment evaluation.
Oncology, Medical July 10th 2023